Atara Biotherapeutics
ATRA
ATRA
35 hedge funds and large institutions have $19.6M invested in Atara Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
81% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 16
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$506K | |
| 2 | +$483K | |
| 3 | +$176K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$143K |
| 5 |
VPC
Vestal Point Capital
New York
|
+$103K |
Top Sellers
| 1 | -$1.41M | |
| 2 | -$873K | |
| 3 | -$787K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$603K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$309K |